Manit Munshi

OverviewAI-generated summary

Manit Munshi's research focuses on Waldenström macroglobulinemia (WM), a rare B-cell lymphoproliferative disorder. His work investigates the efficacy and mechanisms of various therapeutic agents, including ibrutinib, a Bruton's tyrosine kinase (BTK) inhibitor. Munshi has published on the long-term outcomes of ibrutinib monotherapy in treatment-naive and relapsed WM patients, as well as explored combination therapies such as ibrutinib with ulocuplumab or venetoclax. His publications also address challenges in WM diagnosis, including the detection of MYD88L265P and CXCR4 mutations by next-generation sequencing. Munshi's scholarship metrics include an h-index of 19, with 71 total publications and 1,449 citations. He has collaborated with researchers such as Guido Tricot and David E. Mery at the University of Arkansas for Medical Sciences.

Metrics

• h-index: 19
• Publications: 71
• Citations: 1,449